NSE: ASTERDM · 29 October 2026
- Aster DM Quality Care Ltd. (ASTERDM) moved higher during the trading session, gaining 1.46% to close at ₹679.20 compared to its previous close of ₹669.45. The stock opened at ₹671.95 and traded within a daily range of ₹669.65 and ₹682.70.
- The company filed the official transcript of its 18th Annual General Meeting held on 28 September 2026 through video conferencing. Management discussed the post-merger integration of Aster DM Healthcare and Quality Care India, highlighting a combined proforma revenue of ₹9,273 crores and an operating EBITDA of ₹2,013 crores for FY 2025-26. Executives also outlined expansion plans aimed at surpassing 15,000 beds across the network.
- Trading volume was 0.38 times the 20-day average daily volume.
Why is Aster DM Quality Care share price rising on 29 October 2026?
Aster DM Quality Care Ltd. (ASTERDM) moved higher during the trading session, gaining 1.46% to close at ₹679.20 compared to its previous close of ₹669.45. The stock opened at ₹671.95 and traded within a daily range of ₹669.65 and ₹682.70.
The broader market demonstrated positive momentum, with the benchmark Nifty rising by 1.05%. The sector benchmark, Nifty Pharma, also advanced by 0.64%, reflecting a generally supportive environment for healthcare equities. Aster DM Quality Care's upward move aligned moderately with broader market gains, outperforming the sectoral index while staying close to the benchmark's trajectory. Over the short term, the stock has shown resilience, posting a 5-day return of 3.74%, although its 20-day return stands at -7.46%, indicating a recovery from recent corrective phases.
Recent company disclosures highlight ongoing corporate governance updates and integration milestones following the merger of Aster DM Healthcare Limited and Quality Care India Limited. At the 18th Annual General Meeting held on 28 September 2026, transcripts and voting results confirmed shareholder approvals for key resolutions, including the adoption of audited financial statements. Additionally, the company announced board restructuring, noting the retirement of Ms. P.H. Vijaya Deepti and the appointment of Ms. Neela Bhattacherjee as a Non-Executive Independent Director effective 28 September 2026. While these administrative and strategic developments frame the company's current operational phase following the creation of an integrated healthcare network with over 10,800 beds, they serve as broader structural context rather than direct immediate catalysts for today's price action.
4.61 lakh shares traded by 29 October 2026 · 03:25 PM IST. This compares with a 20-day average daily volume of 12.04 lakh shares (0.38 times). The five-day average daily volume was 7.79 lakh shares. Separately, the NSE report for 28 October 2026 showed 1.57 lakh shares delivered, representing 44.40% of that day’s traded volume. The same report recorded 20,615 trades.
No specific corporate announcement or news event was tied directly to today's share price movement. The 1.46% gain appears consistent with a continuation of short-term recovery momentum, supported by a positive broader market environment and broader sector trends.
Latest Company Developments
The company filed the official transcript of its 18th Annual General Meeting held on 28 September 2026 through video conferencing. Management discussed the post-merger integration of Aster DM Healthcare and Quality Care India, highlighting a combined proforma revenue of ₹9,273 crores and an operating EBITDA of ₹2,013 crores for FY 2025-26. Executives also outlined expansion plans aimed at surpassing 15,000 beds across the network.
Provides investors with comprehensive operational metrics and management's strategic vision following the consolidation of integrated healthcare assets.
Aster DM Quality Care announced changes to its Board of Directors following the 18th Annual General Meeting. The company noted the retirement of Ms. P.H. Vijaya Deepti as Non-Executive Independent Director upon the completion of her term and inducted Ms. Neela Bhattacherjee as an Additional Director in the category of Non-Executive Independent Director for a three-year term effective 28 September 2026.
Reflects ongoing governance evolution and committee realignments as the leadership structure adapts to post-merger operational demands.
The company submitted the official voting results and scrutinizer's report for its 18th Annual General Meeting held on 28 September 2026. Shareholders approved all proposed resolutions, including the adoption of standalone and consolidated financial statements for the financial year ended 31 March 2026 and the ratification of cost auditor remuneration.
Formalizes shareholder backing for key financial and administrative resolutions required under regulatory frameworks.
Aster DM Quality Care Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
a press release dated September 04, 2026, titled "Dr. Moopen family picks up additional stake in the Company".
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 20.76% on 30 September 2026. This compares with 15.93% on 13 July 2026, a change of +4.83 percentage points.
The filing reported 35 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Upcoming financial results and board meeting scheduled for 06 November 2026 to consider unaudited results for the quarter and half-year ended 30 September 2026
- Post-merger integration progress and execution of bed capacity expansion milestones toward the 15,000-bed network target
- Delivery volume participation and cash trading turnover trends relative to the 20-day average volume
- Further updates regarding specialized clinical programs, digital health adoption, and app downloads across the integrated healthcare network
More Aster DM Quality Care news and dated analysis →
Frequently Asked Questions
What is the latest Aster DM Quality Care company news?
The company filed the official transcript of its 18th Annual General Meeting held on 28 September 2026 through video conferencing. Management discussed the post-merger integration of Aster DM Healthcare and Quality Care India, highlighting a combined proforma revenue of ₹9,273 crores and an operating EBITDA of ₹2,013 crores for FY 2025-26. Executives also outlined expansion plans aimed at surpassing 15,000 beds across the network.
How strong was Aster DM Quality Care’s trading volume?
4.61 lakh shares traded, 0.38 times the 20-day average daily volume. The price and volume data are dated 29 October 2026 · 03:25 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.